MX9804483A - Modification process. - Google Patents

Modification process.

Info

Publication number
MX9804483A
MX9804483A MX9804483A MX9804483A MX9804483A MX 9804483 A MX9804483 A MX 9804483A MX 9804483 A MX9804483 A MX 9804483A MX 9804483 A MX9804483 A MX 9804483A MX 9804483 A MX9804483 A MX 9804483A
Authority
MX
Mexico
Prior art keywords
modification process
mannose
galactose
containing compound
vivo modification
Prior art date
Application number
MX9804483A
Other languages
Spanish (es)
Inventor
Morten Jorsboe
Janne Brunstedt
Steen Guldager Petersen
Original Assignee
Danisco
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Danisco filed Critical Danisco
Publication of MX9804483A publication Critical patent/MX9804483A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/24—Hydrolases (3) acting on glycosyl compounds (3.2)
    • C12N9/2402—Hydrolases (3) acting on glycosyl compounds (3.2) hydrolysing O- and S- glycosyl compounds (3.2.1)
    • C12N9/2405—Glucanases
    • C12N9/2408—Glucanases acting on alpha -1,4-glucosidic bonds
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
    • C08B37/00—Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
    • C08B37/006—Heteroglycans, i.e. polysaccharides having more than one sugar residue in the main chain in either alternating or less regular sequence; Gellans; Succinoglycans; Arabinogalactans; Tragacanth or gum tragacanth or traganth from Astragalus; Gum Karaya from Sterculia urens; Gum Ghatti from Anogeissus latifolia; Derivatives thereof
    • C08B37/0087—Glucomannans or galactomannans; Tara or tara gum, i.e. D-mannose and D-galactose units, e.g. from Cesalpinia spinosa; Tamarind gum, i.e. D-galactose, D-glucose and D-xylose units, e.g. from Tamarindus indica; Gum Arabic, i.e. L-arabinose, L-rhamnose, D-galactose and D-glucuronic acid units, e.g. from Acacia Senegal or Acacia Seyal; Derivatives thereof
    • C08B37/0096—Guar, guar gum, guar flour, guaran, i.e. (beta-1,4) linked D-mannose units in the main chain branched with D-galactose units in (alpha-1,6), e.g. from Cyamopsis Tetragonolobus; Derivatives thereof
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/82—Vectors or expression systems specially adapted for eukaryotic hosts for plant cells, e.g. plant artificial chromosomes (PACs)
    • C12N15/8241—Phenotypically and genetically modified plants via recombinant DNA technology
    • C12N15/8242—Phenotypically and genetically modified plants via recombinant DNA technology with non-agronomic quality (output) traits, e.g. for industrial processing; Value added, non-agronomic traits
    • C12N15/8243—Phenotypically and genetically modified plants via recombinant DNA technology with non-agronomic quality (output) traits, e.g. for industrial processing; Value added, non-agronomic traits involving biosynthetic or metabolic pathways, i.e. metabolic engineering, e.g. nicotine, caffeine
    • C12N15/8245—Phenotypically and genetically modified plants via recombinant DNA technology with non-agronomic quality (output) traits, e.g. for industrial processing; Value added, non-agronomic traits involving biosynthetic or metabolic pathways, i.e. metabolic engineering, e.g. nicotine, caffeine involving modified carbohydrate or sugar alcohol metabolism, e.g. starch biosynthesis
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/90—Isomerases (5.)

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Nutrition Science (AREA)
  • Materials Engineering (AREA)
  • Plant Pathology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Emergency Medicine (AREA)
  • Cell Biology (AREA)
  • Physics & Mathematics (AREA)
  • Biophysics (AREA)
  • Polymers & Plastics (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Breeding Of Plants And Reproduction By Means Of Culturing (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Transition And Organic Metals Composition Catalysts For Addition Polymerization (AREA)

Abstract

An in vivo modification process is described. The in vivo modification process affects the mannose-to-galactose ratio of either an organism (or part thereof) capable of producing a mannose/galactose containing compound or of a mannose/galactose containing compound thereof.
MX9804483A 1995-12-04 1998-06-04 Modification process. MX9804483A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB9524752.4A GB9524752D0 (en) 1995-12-04 1995-12-04 Modification process

Publications (1)

Publication Number Publication Date
MX9804483A true MX9804483A (en) 1998-09-30

Family

ID=10784871

Family Applications (1)

Application Number Title Priority Date Filing Date
MX9804483A MX9804483A (en) 1995-12-04 1998-06-04 Modification process.

Country Status (8)

Country Link
EP (1) EP0866869A2 (en)
JP (1) JP2000502252A (en)
CN (1) CN1207772A (en)
AU (1) AU1193997A (en)
BR (1) BR9612773A (en)
GB (1) GB9524752D0 (en)
MX (1) MX9804483A (en)
WO (1) WO1997020937A2 (en)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6311808B1 (en) 1996-02-09 2001-11-06 Continental Teves Ag & Co., Ohg Combined service and parking brake system
GB9710990D0 (en) * 1997-05-28 1997-07-23 Danisco Modification process
GB9807520D0 (en) * 1998-04-09 1998-06-10 Univ Wales Medicine Modified biological material
GB9810997D0 (en) * 1998-05-21 1998-07-22 Unilever Plc Genes & enzymes
WO2000028046A1 (en) * 1998-11-11 2000-05-18 Societe Des Produits Nestle S.A. Coffea arabica mannanase
EP1138771A1 (en) * 2000-03-30 2001-10-04 Societe Des Produits Nestle S.A. Coffee endo-mannanase
EP1453982A2 (en) * 2001-11-06 2004-09-08 The University of British Columbia Modulating urea degradation in wine yeast
AU2003290793A1 (en) 2002-11-14 2004-06-15 Pioneer Hi-Bred International, Inc. Genes for galactomannan production in plants and methods of use
JP4960591B2 (en) * 2004-12-14 2012-06-27 味の素ゼネラルフーヅ株式会社 Anti-allergen composition containing mannooligosaccharides
US7678556B2 (en) 2006-11-21 2010-03-16 Cornell Research Foundation, Inc. Beta-mannanase from coffee berry borer, Hypothenemus hampei, and uses thereof
EP2084264A1 (en) 2007-03-09 2009-08-05 Corning Incorporated Three dimensional gum matrices for cell culture, manufacturing methods and methods of use

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK153568C (en) * 1985-02-12 1988-12-05 Novo Industri As ALFA-GALACTOMANNANGALACTOSIDASE AND AGENTS CONTAINING THIS
EP0255153B1 (en) * 1986-06-03 1995-01-18 Unilever N.V. Production of guar alpha-galactosidase by hosts transformed by recombinant DNA methods
JPH09502349A (en) * 1993-09-08 1997-03-11 ニューヨーク・ブラッド・センター・インコーポレイテッド Recombinant α-galactosidase enzyme and cDNA encoding the same

Also Published As

Publication number Publication date
WO1997020937A2 (en) 1997-06-12
EP0866869A2 (en) 1998-09-30
WO1997020937A3 (en) 1997-11-27
GB9524752D0 (en) 1996-02-07
BR9612773A (en) 2001-01-02
CN1207772A (en) 1999-02-10
JP2000502252A (en) 2000-02-29
AU1193997A (en) 1997-06-27

Similar Documents

Publication Publication Date Title
EP0758028A3 (en) Process of producing graphite fiber
AU7062496A (en) Process for the production of Bis(silyalkyl)-disulfanes
AU6513096A (en) Treatment of fabrics
NZ313008A (en) Novel process for the production of atorvastatin
CA2211314A1 (en) A process for preparing certain aza cyclohexapeptides
AU4867396A (en) Process of preparing therapeutic compositions containing nanoparticles
AU695352B2 (en) Process for producing derivatives of 4a,5,9,10,11,12,-hexahydro-6h-benzofuro{3a,3,2-ef}{2} benzazepine
MX9804483A (en) Modification process.
AU6328696A (en) Treatment of hemoglobinopathies
AU6056890A (en) Method of producing d-pantolactone
AU7623694A (en) Method of producing liquor
AU5216893A (en) Process for producing hydrogen peroxide
ZA962847B (en) Treatment of traveller's diarrhea.
AU7096891A (en) Process of producing linear alpha-olefins
AU6829696A (en) Treatment of solutions
AU4137993A (en) A process of producing solid sodium cyanide
MX9603087A (en) Process to obtain substituted aminocarbonyltriazolinones.
AU5117690A (en) Desulfurising agent and process of producing it
AUPN658795A0 (en) Method of producing alpha 2, 3 sialyltransferase
HU9600499D0 (en) Process for producing of ivermectin
EG20782A (en) Process of preparation streptogramines
AU3407793A (en) Production of hydrogen
AU4495396A (en) Process for the manufacture of buttons for clothing
AU5566890A (en) Method of producing sake
GB9504913D0 (en) Production of trialkoxypropane